Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis.
Roy A, Brenneman RJ, Hogan J, Barnes JM, Huang Y, Morris R, Goddu S, Altman M, Garcia-Ramirez J, Li H, Zoberi JE, Bullock A, Kim E, Smith Z, Figenshau R, Andriole GL, Baumann BC, Michalski JM, Gay HA.
Roy A, et al.
Clin Transl Radiat Oncol. 2021 May 13;29:47-53. doi: 10.1016/j.ctro.2021.05.004. eCollection 2021 Jul.
Clin Transl Radiat Oncol. 2021.
PMID: 34136665
Free PMC article.